Bruce D. Hammock

Bruce D. Hammock

University of California Davis
在 ucdavis.edu 的电子邮件经过验证
被引用次数：88115
xenobiotic metabolism epoxide hydrolase esterase nanobodies pain
Guido Jenster

Guido Jenster

Professor of Experimental Urological Oncology
在 erasmusmc.nl 的电子邮件经过验证
被引用次数：32245
Prostate Cancer Markers Extracellular Vesicles lncRNA Nanobodies
jan steyaert

jan steyaert

VIB-VUB center for Structural Biology, Brussels
在 vub.ac.be 的电子邮件经过验证
被引用次数：23389
Antibody engineering Nanobodies Protein design G protein-coupled receptors GPCRs
Paul Declerck

Paul Declerck

Professor KU Leuven
在 kuleuven.be 的电子邮件经过验证
被引用次数：16600
(Human) monoclonal antibodies nanobodies gene therapy biosimilars drug development
Eefjan Breukink

Eefjan Breukink

Full Professor, Utrecht University
在 uu.nl 的电子邮件经过验证
被引用次数：16373
membrane biochemistry antibiotics bacterial cell wall synthesis VHH nanobodies
Mitchell Ho

Mitchell Ho

Senior Investigator, National Cancer Institute, NIH
在 mail.nih.gov 的电子邮件经过验证
被引用次数：9208
antibody therapeutics antibody engineering nanobodies phage display proteoglycans
Björn Rissiek

Björn Rissiek

Group Leader at University-Clinic Hamburg-Eppendorf, Department of Neurology
在 uke.de 的电子邮件经过验证
被引用次数：3548
Immunology Neuroimmunology regulatory T cells Nanobodies purinergic signalling
Ernesto Moreno Frias

Ernesto Moreno Frias

Universidad de Medellín, Colombia
在 udemedellin.edu.co 的电子邮件经过验证
被引用次数：3511
structural bioinformatics protein engineering drug design cancer immunotherapy nanobodies
Lucía Chávez-Gutiérrez

Lucía Chávez-Gutiérrez

University of Leuven / VIB Center for Brain & Disease Research
在 kuleuven.vib.be 的电子邮件经过验证
被引用次数：3426
Intramembrane Proteases Alzheimer's disease Nanobodies
Fikadu G Tafesse

Fikadu G Tafesse

Oregon Health & Science University
在 ohsu.edu 的电子邮件经过验证
被引用次数：3346
Host-pathogen interaction/Lipid Biochemistry antibody-mediated immunity nanobodies
1 - 10